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Propolis is a bee-collected natural product and has been proven to have various bioactivities. This study tested the eﬀects of
Chinese propolis and Brazilian propolis on streptozotocin-induced type 1 diabetes mellitus in Sprague-Dawley rats. The results
showedthatChinesepropolisandBrazilianpropolis signiﬁcantlyinhibited body weightlossandbloodglucoseincrease in diabetic
rats.In addition, Chinese propolis-treated rats showed an 8.4% reduction of glycated hemoglobin levels compared with untreated
diabetic rats. Measurement of blood lipid metabolism showed dyslipidemia in diabetic rats and Chinese propolis helped to reduce
total cholesterol level by 16.6%. Moreover, oxidative stress in blood, liver and kidney was improved to various degrees by both
Chinese propolis and Brazilian propolis. An apparent reduction in levels of alanine transaminase, aspartate transaminase, blood
urea nitrogen and urine microalbuminuria-excretion rate demonstrated the beneﬁcial eﬀects of propolis in hepatorenal function.
All these results suggested that Chinese propolis and Brazilian propolis can alleviate symptoms of diabetes mellitus in rats and
these eﬀects may partially be due to their antioxidant ability.
1.Introduction
Propolis, a resinous substance collected from the buds of
certain trees by bees, is a traditional herb medicine in many
countries. More than 300 components have been found in
propolis, mainly composed of phenolic compounds (e.g.,
ﬂavonoids, aromatic compounds), terpenes and essential oil
[1–3]. Propolis has been proven to have various bioactivities
that are anti-pathogenic, immunoregulatory, antioxidative,
anti-tumor, hepatoprotective and anti-inﬂammatory [3–5].
InChina,propoliswasauthorizedasanewmaterialmedicine
and embodied in the Chinese Pharmacopeia in 2005 [6].
Diabetes mellitus leads to a series of complications such
as retinopathy, neuropathy, kidney failure, heart disease and
stroke. Therefore, diabetes mellitus can be a severe threat
to public health and raises economic burden in the world
[7]. It is estimated that the economic cost of diabetes came
up to $174 billion in the USA in 2007 [8]. Due to the
huge medical expenditure and complicated pathobiology of
diabetes, research has focused on herbal medicine that might
improve glucose control and lower the risk of complications
[9–11].
Streptozotocin (STZ), a nitrosourea derivative isolated
from Streptomyces achromogenes,c a nc a u s ed i a b e t e sm e l l i t u s
in rodents by selectively ruining pancreatic β-cells. STZ-
induced diabetes in rodents is characterized by hyper-
glycemia, glucosuria, polyphagia, polydipsia, polyuria, body
weight loss, hypoinsulinemia and hyperlipidemia [12, 13],
and has been widely accepted as a model of type 1 diabetes
mellitus for the studies of hyperglycemia and insulinopenia
[14]. STZ is also used to develop a model of macro- or
microvascular complications in diabetes [15, 16].
Our previous studies have shown that Chinese propolis
helped to reduce fasting blood glucose (FBG) and improve
oxidative stress and lipid metabolism in alloxan-induced
diabetic rats [17]. In addition, clinic application of propolis
beneﬁted to control blood glucose [18]. A systematic study,
therefore, was required to verify the antidiabetic eﬀects of
propolis and to reveal its possible mechanism. This study
determined the eﬀects of Chinese propolis and Brazilian
propolis on STZ-induced type 1 diabetes in rats. The aims
were to: (i) verify the antidiabetic eﬀects of propolis; (ii)
reveal its possible mechanism and (iii) compare the eﬀects
of Chinese propolis and Brazilian propolis.2 Evidence-Based Complementary and Alternative Medicine
2.Materialsand Methods
2.1. Drugs and Reagents. Chinese propolis, produced by
Apis. mellifera bees, was collected in Shandong Province,
China, in 2007 and the main plant origin was the poplar
(Populus sp.). Brazilian propolis (green or alecrim propolis),
produced by A. mellifera bees, was obtained from the
Hangzhou BEEWORDS Apiculture Co. Ltd. (Hangzhou,
China). Polyethylene glycol (PEG) 400 and 6000 were pur-
chased from the Shanghai Pudong Gaonang Chemical Fac-
tory(Shanghai,China);STZwaspurchasedfromtheALEXIS
Corporation (Switzerland). Liquid kits of glucose, total
cholesterol (TC), triglyceride (TG), high-density lipoprotein
cholesterol (HDL-C), low-density lipoprotein cholesterol
(LDL-C), alanine transaminase (ALT), aspartate transami-
nase(AST),bloodureanitrogen(BUN),creatinineandurine
albumin were purchased from DiaSys Diagnostic Systems
(Shanghai)Co., Ltd,China.Test kitsofsuperoxidedismutase
(SOD), glutathione peroxidase (GSH-PX), malonaldehyde
(MDA), nitric oxide (NO) and nitric synthetase (NOS)
were obtained from Nanjing Jiancheng Biology Engineering
Research Institute (Nanjing, China). NycoCard(r) HbA1c
test kit was purchased from Axis-shield Poc AS (Norway).
2.2. Laboratory Animals. Male Sprague–Dawley (SD) rats
weighing 200 ± 20g were purchased from the Shanghai Lab-
oratory Animal Center of the Chinese Academy of Sciences
[Certiﬁcate No: SCXK(Shanghai) 2003-0003]. Afterwards,
rats were reared at the Research Center of the Laboratory
of Animal Science, Zhejiang College of Traditional Chinese
Medicine (Hangzhou, China). The rats were acclimatized
for 2 weeks prior to the experiment, during which time
they were given free access to water and standard rat food.
The animals were kept under a condition of physiological
day/night rhythm, an ambient temperature of 23 ± 1◦C,
a humidity of 50–70% and noise <50dB, which were in
accordance with the Helsinki guidelines. The experimental
protocol was approved by the Animal Ethics Committee of
the Zhejiang University.
2.3. Induction of Diabetes Mellitus. Rats were fasted
overnight before experiments. Fasted rats were injected
intravenously through the tail vena with a single dose of 2%
STZ (50mgkg–1) dissolved in physiological saline solution
(0.1mmol citric acid/L). FBG and other biochemical indices
were determined 7 days later. Thirty-two rats (mean weight:
270 ± 40g) having an FBG concentration between 15 and
27mmol L–1 were selected for the type 1 diabetes mellitus
model. Diabetic rats were randomly divided into groups of
model, Chinese, Brazilian and positive groups, with eight
rats in each group. An additional eight rats without STZ
induction were selected as the normal group.
2.4. Method of Drug Administration. Both Chinese and
Brazilian propolis were extracted by 95% ethanol and then
the two extracts were mixed with PEG 400 and PEG 6000 in
a ratio of 1 : 1 : 1, respectively. The mixture was dissolved
in physiological saline (10mg propolis mL–1)f o rs u b s e q u e n t
use. Physiological saline administered to normal, model and
positive groups rats were also mixed with the corresponding
concentration of PEG. These solutions were given to rats by
oral intubation twice daily (09:00 and 15:00h), continuously
for 8 weeks. The dosage of each group is shown below.
Each rat in the Chinese group received intra-gastrically a
dose of 10mg Chinese propolis per 100g body weight.
Each rat in the Brazilian group received intra-gastrically
a dose of 10mg Brazilian propolis per 100g body weight.
Glucobay contains the active drug acarbose and helps
to control blood sugar in diabetic patients. Glucobay was
dissolved in physiological saline mixed with PEG at a con-
centration of 1mgmL–1; each rat belonging to the positive
group received intra-gastrically a dose of 1mg glucobay per
100g body weight.
Eachratbelongingtothenormal groupandmodelgroup
received intra-gastrically a dose of 1mL physiological saline
mixed with PEG per 100g body weight.
2.5. Method of Measurement. The weight and FBG of all
rats were measured weekly. Prior to sacriﬁcing, rats were
housed in metabolic cages for collecting 24-h urine to
measure the urine biochemical indexes. Once rats were
sacriﬁced, blood from the abdominal aorta was collected
to measure the biochemical indexes. Hitachi 7020 entire
automatic biochemistry analyzers (Hitachi Co. Ltd., Japan)
were used to determine the content of TC, TG, HDL-
C, LDL-C, BUN, serum creatinine (SCr), urine creatinine
(UCr) and urine microalbumin. BT-815A semi-automatic
biochemical analyzer (Shanghai Sanco Instrument Co. Ltd.,
China) was used to determine MDA, catalase (CAT), GSH-
PX and SOD.glycated hemoglobin (HbA1c)was determined
by the NycoCard Reader (Axis-Shield Company, Norway).
Endogenous creatinine clearance rate (CCR) was calculated
from the values of SCr, UCr and total 24-h urine volume. A
24-h urinary albumin-excretion rate (UAER) was calculated
by urinary albumin concentration × 24-h urine volume
(in mL). Kidneys and livers of dissected rats were removed
and weighed. All the measurements were carried out in
accordance with the instructions from manufacturers.
2.6. Data Analysis. Data were analyzed by the Statistical
Package for the Social Sciences version 16 (SPSS16.0). One-
way analysis of variance (ANOVA) test was performed and
post hoc multiple comparisons were conducted with LSD.
Results were presented as mean ± standard deviation (SD).
A P-value <.05 was regarded as statistically signiﬁcant.
3.Results
3.1. Inhibition on STZ-Induced Body-Weight Loss in Rats.
Administration started 7 days following the injection of STZ
and lasted 8 weeks. All rats were weighed after 10 h of fasting
overnight before treatment (Week 0) and every week during
treatment.
AsshowninFigure 1,thebodyweightofSTZ-treatedrats
was signiﬁcantly lower than that of the normal rats without
STZ treatment over the experimental period (P < .01),Evidence-Based Complementary and Alternative Medicine 3
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Figure 1: Inhibition on body-weight loss. Values represent the
means ± SD, n = 8. ∗P < .05 and ∗∗P < .01, compared with
the model group. Model group and normal group rats: received
physiological saline; Chinese group rats: received Chinese propolis;
Brazilian group rats: received Brazilian propolis and Positive group
rats: received glucobay.
indicatingtheinductionofdiabetesbySTZ.The bodyweight
of all propolis-treated rats increased at various levels. The
most interesting thing was that Chinese propolis-treated
rats (Chinese group) exhibited a signiﬁcantly elevated body
weight during the whole period of treatment (P < .01 or
P < .05) compared with the rats in the model group (P <
.01 or P < .05). Moreover, the Brazilian propolis-treated
rats (Brazilian group) showed a signiﬁcantly elevated body
weight from the 5th week to the 8th week (P < .01 or P <
.05), compared with the rats in the model group in the same
period. Thus, both Chinese propolis and Brazilian propolis
were considered to preventbody-weight loss induced by STZ
in diabetic rats.
3.2. Improvement of Blood Glucose Level of Diabetic Rats. All
rats were fasted for 10h overnight followed by FBG-level
measurement during the experiment. HbAlc levels in rats
were measured before sacriﬁce. As shown in Figures 2 and 3,
FBG and HbAlc levels in model group rats were signiﬁcantly
elevated compared with normal rats (P < .01). From Weeks
1 to 5 and at Week 8, FBG levels in Chinese group rats
decreased signiﬁcantly compared with those in the model
group rats (P < .05 or P < .01). From Weeks 3 to 5 and from
the7thtothe8thweek, FBGlevelsinthe Braziliangrouprats
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Figure 2: Reduction of fastingblood glucoselevel. Values represent
the means ± SD, n = 8. ∗P < .05 and ∗∗P < .01, compared with
the model group. Model group and normal group rats: received
physiological saline; Chinese group rats: received Chinese propolis;
Brazilian group rats: received Brazilian propolis and Positive group
rats: received glucobay.
were evidently lower than those in model group rats (P < .05
or P < .01). At Week 6, propolis showed no improvement on
FBG levels in diabetic rats. As shown in Figure 3,t h eH b A l c
level was signiﬁcantly reduced from 8 ± 0.35% in model
group rats to 7.33 ± 0.41% in Chinese group rats (P < .01).
3.3. Restoration of STZ-Damaged Hepatorenal Function.
Diabetes mellitus can damage tissues and organs seriously.
Therefore, the protective eﬀect of propolis on the kidneys
and renal function was measured. In our study, the levels of
kidney weight (KW), kidney weight/body weight (KW/BW),
SCr, BUN, CCR, and UAER were used to evaluate the degree
of renal damage. Table 1 showed that BUN, UAER, CCR,
KW and KW/BW levels in healthy rats were clearly lower
in the normal group rats than those in the model group
rats (P < .01), whereas SCR levels did not diﬀer signiﬁcantly
between diabetic rats and normal rats. Compared with the
model group rats, BUN levels in the Brazilian group were
signiﬁcantly suppressed (P < .01); KW/BW levels in the
Chinese group were obviously inhibited (P < .05); propolis-
treated rats had a similar UAER, which was obviously
reduced (P < .05).
Liver weight (LW), liver weight/body weight (LW/BW),
ALT and AST were used to estimate the degree of hepatic4 Evidence-Based Complementary and Alternative Medicine
Table 1: Protection against STZ-induced renal damage.
Group Model Chinese Brazilian Positive Normal
KW (g) 3.10 ± 0.30 3.31 ± 0.17 3.24 ± 0.22 3.18 ± 0.43 2.54 ± 0.21∗∗
KW/BW (‰) 11.91 ± 0.72 10.74 ± 0.67∗ 11.24 ± 0.76 10.38 ± 1.55∗∗ 5.68 ± 0.43∗∗
BUN (mmolL–1) 14.19 ± 2.41 12.66 ± 3.59 9.23 ± 1.89∗∗ 10.50 ± 3.02∗∗ 4.14 ± 0.70∗∗
SCr (umol L–1) 57.75 ± 3.33 56.25 ± 4.23 56.25 ± 3.41 59.25 ± 3.96 57.25 ± 5.42
UAER (mg/24h) 0.45 ± 0.21 0.27 ± 0.16∗ 0.26 ± 0.18∗ 0.19 ± 0.13∗∗ 0.12 ± 0.05∗∗
CCR (mL min–1)2 . 0 2 ± 0.53 1.97 ± 0.25 1.97 ± 0.29 1.08 ± 0.54∗∗ 0.81 ± 0.43∗∗
Values represent the mean ± SD, n = 8. KW, kidney weight; BW, body weight; BUN, blood urea nitrogen; SCr, serum creatinine; UAER, urinary albumin-
excretion rate; CCR, creatinine clearance rate.
∗P < .05 and ∗∗P < .01, compared with the model group.
Table 2: Prevention of STZ-induced hepatic damage.
Group Model Chinese Brazilian Positive Normal
LW (g) 11.61 ± 0.73 13.30 ± 0.68∗∗ 12.73 ± 1.04∗ 13.40 ± 1.03∗∗ 12.09 ± 1.24
LW/BW (‰) 44.94 ± 5.02 43.22 ± 2.70 44.12 ± 2.81 43.63 ± 6.80 27.01 ± 1.68∗∗
ALT (IU L–1) 128.67 ± 51.06 93.00 ± 18.75∗ 85.83 ± 21.78∗∗ 123.83 ± 34.61 45.83 ± 5.91∗∗
AST (IU L–1) 250.17 ± 65.67 195.50 ± 23.74∗ 172.50 ± 13.28∗∗ 226.67 ± 64.85 127.67 ± 7.99∗∗
Values represent the mean ± SD, n = 8. LW, liver weight; ALT, alanine transaminase; AST, aspartate transaminase.
∗P < .05 and ∗∗P < .01, compared with the model group.
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Figure 3: Changes in serum HbAlc level. Each column represents
the means ± SD, n = 8. ∗∗P < .01, compared with the model group.
HbAlc, glycosylated hemoglobin.
damage. Table 2 shows that the levels of AST, ALT and
LW/BW in healthy rats were clearly lower in the normal
group rats than those in the model group rats (P <
.01), whereas LW/BW levels showed no marked diﬀerence
between model rats and normal rats. Compared with model
rats, LW levels in Chinese and Brazilian groups signiﬁcantly
increased (P < .01 and P < .05, resp.); levels of AST and ALT
in Chinese and Brazilian groups decreased signiﬁcantly (P <
.05 and P < .01, resp.).
3.4. Suppression of Serum Oxidative Stress. Free radical plays
an important role in the onset of diabetes mellitus and
its complications. Table 3 shows that both Chinese propolis
and Brazilian propolis ameliorated blood oxidative stress
in diabetic rats at various degrees. Chinese propolis, but
not Brazilian propolis, signiﬁcantly inhibited the MDA level
(P < .01). In contrast, Brazilian propolis, but not Chinese
propolis, obviously reduced the NOS level and increased
the SOD level (P < . 0 1 ) .T h eG S H - P xl e v e ld i dn o tc h a n g e
signiﬁcantly in diabetic rats compared with normal rats.
Neitherpropolisnorpositivedrughadanyeﬀectonthelevels
of NO and CAT.
3.5. Protection against Hepatorenal Oxidative Stress. Results
of the eﬀect of propolis on hepatorenal oxidative stress are
presented in Table 4. Increased MDA levels in liver and
kidney indicated an exasperated oxidative stress in diabetic
rats. Liver antioxidase activity in model group rats was lower
than thatin normalgrouprats,as evidencedbythedecreased
level of SOD activity (P < .05). Chinese propolis showed no
improvement on MDA level and antioxidase activity in liver,
whereas Brazilian propolis had an apparent improved eﬀect
on liver MDA and SOD level (P < .05 and P < .01, resp.).
No signiﬁcant diﬀerences in liver CAT level were detected
between model rats and normal rats, but liver CAT levels in
Brazilian group rats visibly increased compared with model
rats (P < .05). Renal MDA levels in Chinese group and
Brazilian group rats signiﬁcantly decreased (P < .05 and P <
.01, resp.), compared with those in model group rats. Renal
CAT and SOD levels in model rats were lower than those in
normal rats (P > .05), whereas renal GSH-Px levels in model
grouprats signiﬁcantly increased compared with normal rats
(P < .05). Although renal SOD and CAT levels did not diﬀer
obviously between model group rats and normal group rats,
both Brazilian and Chinese propolis obviously increased the
CAT level (P < .05).Evidence-Based Complementary and Alternative Medicine 5
Table 3: Suppression of blood oxidative stress.
Group Model Chinese Brazilian Positive Normal
NO (μmol L–1) 19.40 ± 9.04 14.70 ± 2.96 16.26 ± 2.69 19.13 ± 5.60 10.41 ± 1.60∗∗
NOS (U mL–1) 46.93 ± 4.83 46.98 ± 3.21 36.47 ± 6.38∗∗ 36.97 ± 3.35∗∗ 35.30 ± 6.04∗∗
SOD (U mL–1) 39.42 ± 14.30 44.46 ± 11.66 54.53 ± 3.41∗∗ 57.16 ± 4.07∗∗ 53.24 ± 5.51∗∗
CAT (U mL–1)9 . 6 5 ± 0.83 9.97 ± 1.04 11.04 ± 1.07 9.60 ± 1.11 12.69 ± 2.11∗∗
GSH-Px (μmol L–1) 687.88 ± 48.29 682.35 ± 48.89 663.38 ± 80.87 674.76 ± 44.08 692.22 ± 35.85
MDA (nmolL–1)5 . 1 5 ± 0.55 3.61 ± 0.80∗∗ 4.80 ± 2.11 2.50 ± 0.59∗∗ 3.27 ± 0.41∗∗
Values represent the mean ± SD, n = 8 .N O ,n i t r i co x i d e ;N O S ,n i t r i cs y n t h e t a s e ;S O D ,s u p e r o x i d edismutase;CAT, catalase;GSH-px, glutathione peroxidase;
MDA, malonaldehyde.
∗P < .05 and ∗∗P < .01, compared with the model group.
Table 4: Reversal of hepatorenal oxidative stress.
Group Model Chinese Brazilian Positive Normal
Liver SOD (U mL–1) 69.33 ± 6.90 81.38 ± 16.79 91.65 ± 17.62∗∗ 76.43 ± 9.32 86.56 ± 13.57∗
Liver CAT (U mL–1) 83.28 ± 6.28 94.57 ± 19.22 97.95 ± 19.47 87.24 ± 10.24 97.32 ± 12.54
Liver GSH (μmolL–1) 265.18 ± 27.86 338.09 ± 26.48 358.99 ± 146.43∗ 306.55 ± 68.18 314.78 ± 46.19
Liver MDA (nmolL–1)2 . 6 7 ± 0.66 2.11 ± 0.49 1.84 ± 1.10∗ 1.84 ± 0.76∗ 1.82 ± 0.52∗
Renal SOD (U mL–1) 80.34 ± 2.42 81.44 ± 12.34 84.09 ± 7.04 92.44 ± 16.93 84.99 ± 3.78
Renal CAT (U mL–1) 30.69 ± 2.48 37.49 ± 3.17∗ 37.27 ± 2.18∗ 42.73 ± 9.91∗∗ 34.80 ± 4.48
Renal GSH (μmolL–1) 729.80 ± 70.47 660.75 ± 113.02 653.66 ± 253.09 639.71 ± 124.49 554.75 ± 45.22∗
Renal MDA (nmolL–1)2 . 8 3 ± 0.68 2.06 ± 0.28∗ 1.85 ± 0.29∗∗ 2.16 ± 0.42∗ 1.97 ± 0.31∗∗
Values represent the mean ± SD, n = 8.
∗P < .05 and ∗∗P < .01, compared with the model group.
3.6. Amelioration of Blood Lipid Metabolism. Disturbance of
lipid metabolism emerges in diabetic rats. Table 5 showed
that levels of LDL-C, HDL-C, and TC did not change
noticeably in model group rats, whereas TG level was greatly
i n c r e a s e dc o m p a r e dwi t ht h a ti nn o rm a lgr o u pra t s( P <.05).
Propolistreatment showed noobviousreductionin TG level,
butTClevelinChinesegroupratswasdecreasedby16.6%(P
< .05).
4.Discussion
Hyperglycemia is regarded as one of the main causes of
diabetes complications, and the improvement of glycemic
control reduces the incidence of complications [19–21].
HbAlc is an ideal indicator for long-term glycemic control
and the risk of diabetic complications. A 1% increase in
the HbA1c level is accompanied by a signiﬁcant increase in
incidence of cardiovascular events, whereas a decrease in the
HbAlc level to 6.5% is accompanied by a reduction of 10%
in the risk of macro- and microvascular diseases [22, 23].
Water extracts ofBrazilian propolisand an active constituent
caﬀeoylquinic acid suppressed postprandial blood glucose
rise in SD rats by inhibiting maltase activities [24]. Our
previous works showed that ethanol extracts and water
extracts of Chinese propolis helped reduce levels of FBG and
HbAlc in alloxan-induced diabetic rats but had no eﬀect
on postprandial blood glucose in healthy mice [25]. In this
study,ChineseandBrazilianpropolissuppressedtheincrease
of blood glucose levels and weight loss in diabetic rats.
Compared with model group rats, an 8.4% reduction of the
HbAlclevelinChinese propolis-treated rats(P < .01)further
conﬁrmed the hypoglycemic eﬀect of Chinese propolis.
TheseresultssuggestthatChineseandBrazilianpropolismay
prevent the progression of diabetes mellitus by a diﬀerent
action pathway.
Diabetes can damage hepatorenal function and lead to
diabetic nephropathy (DN). It is estimated that DN aﬀects
15–25% of type 1 diabetes patients and 30–40% of type 2
diabetes patients [26]. Microalbumin (from a 24-h urine
collection), SCr, CCR and BUN are important prognostic
markers for kidney disease and are useful measurements of
glomerular ﬁltration rate, whereas ALT and AST are com-
monly used for screening liver problems. Brazilian propolis
showed an obvious inhibitory eﬀect on BUN level and both
Chinese and Brazilian propolis decreased the UAER, ALT
and AST levels. These results demonstrated the protection
eﬀect of propolis on hepatorenal function in diabetic rats.
This conclusionwas consistent with several previous reports,
which showed that propolis and its active constituent caﬀeic
acid phenethyl ester (CAPE) have apparent therapeutic
eﬀects on liver and kidney lesions in animal models [27–30].
Multifold pathways, including increased polyol pathway
ﬂux, increased hexosamine pathway,production ofadvanced
glycation end product (AGE) and protein kinase C (PKC)
activation, are involved in diabetic complications. Increased
reactive oxygen species (ROS), induced by hyperglycemia-
activated electron-transport chain in mitochondria mainly,
are believed to be an underlying mechanism linking all of
these factors (Figure 4)[ 31, 32]. Over-expression of SOD or
uncoupling proteins (UCPs) may block the mitochondrial
electron-transport chain and result in a reduction of ROS
and deactivation of these pathways [31]. Clinical trials also6 Evidence-Based Complementary and Alternative Medicine
Table 5: Regulation of blood lipid metabolism (mmol L−1).
Group Model Chinese Brazilian Positive Normal
LDL-C 0.36 ± 0.02 0.30 ± 0.12 0.32 ± 0.05 0.30 ± 0.09 0.34 ± 0.05
HDL-C 0.96 ± 0.21 0.83 ± 0.12 0.84 ± 0.17 0.92 ± 0.17 0.97 ± 0.16
TG 1.90 ± 0.47 1.75 ± 0.65 1.62 ± 0.44 1.91 ± 0.86 1.11 ± 0.27∗
TC 1.86 ± 0.33 1.57 ± 0.22∗ 1.66 ± 0.24 1.75 ± 0.27 1.71 ± 0.21
Valuesrepresent themean ±SD,n =8.LDL-C, low-densitylipoprotein-cholestereol;HDL-C, high-densitylipoprotein-cholestereol;TG,triglyceride;TC,total
cholesterol.
∗P < .05 and ∗∗P < .01, compared with the model control group.
Hyperglycemia
NAD(P)H oxidase Mitochondrial pathway Xanthine oxidase
Increase in ROS Increase in RNS
Oxidative stress Peroxynitrite
AGE production
Polyol pathway PKC pathway
Hexosamine pathway
Figure 4: ROS as a common upstream event of diabetes. ROS are believed to be an underlying mechanism of diabetes. Hyperglycemia
induced oxidative stress by stimulating mitochondrial pathway, NAD(P)H oxidase and xanthine oxidase, and subsequently activated
various pathways including PKC pathway, hexosamine pathway, polyol pathway, production of AGE and so on. In addition, hyperglycemia
disregulated the expression of reactive nitrogen species (RNS) which reacts with superoxide forming peroxynitrite, a highlyreactive oxidant.
In this experiment, Chinese and Brazilian propolis were certiﬁcated to inhibit the increase of MDA and improve the antioxidase activity in
STZ-damagedrats.Inaddition,Brazilianpropolisdecreased serumNOSlevel,whichsuggestedthattheimprovementofpropolisondiabetes
may partially be attributed to the inhibition of oxidative stress.
proved that improvement of oxidative stress may prevent
the progression of both type 1 and type 2 diabetes [33, 34].
Propolis has a strong antioxidative activity and is conﬁrmed
to inhibit increase of MDA level and improve antioxidase
activity in the animal model and patients [35–37]. Previous
experiments reported that propolis can prevent tissue dam-
age from oxidative stress by decreasing the overproduction
of MDA and superoxide anion and by restoring respiratory
control ration in mitochondrial tissue [38, 39]. In this
experiment, all results suggested that the protective eﬀect
of propolis on hepatorenal function is partially attributed
to antioxidant activity and it may act by aﬀecting the
mitochondrial respiratory chain. In addition, we found that
not all antioxidase levels in diabetic rats were decreased,
and a clearly increased kidney GSH level in model rats was
detected, which is identical to some other reports [36, 37].
Based on the results in Tables 3 and 4, we concluded that
Brazilian propolis had a more comprehensive antioxidant
eﬀect than Chinese propolis.
NO, synthesized by various NOS, is an important mes-
senger molecule and brings both beneﬁcial and deteriorating
eﬀects on the human body. Excessive NO reacts with
superoxide to form a strong oxidant peroxynitrite (Figure 4),
which is linked to various diseases including diabetes [40].
Normally, type 1 and type 2 diabetes patients are associated
with dysfunction of the endothelial cell, which decreases
the bioavailability of NO and leads to vasoconstriction
and hypertension [41]. Scavenging of ROS by antioxidants
helps to enhance NO bioavailability and alleviate tissue
damage[42].However,mediatedbyinﬂammatory factorand
other cytokines, increased NO levels are found in diabetic
patients and in the animal model [42, 43]. Overproduction
of NO promotes the progression of diabetic retinopathy and
early-stage DN; hence the inhibition of increased NO or
NOS may prevent progression [42, 43]. In this experiment,
we found a higher level of NO and NOS in model rats
compared with normal rats. Propolis has an obvious anti-
inﬂammatory eﬀect and inhibits the increase of NOS inEvidence-Based Complementary and Alternative Medicine 7
the animal model [44]. Brazilian propolis, as an inhibitor of
NOS through an anti-inﬂammatory eﬀect, may decrease the
level of NO.
Type 1 and type 2 diabetes present a diﬀerent dyslipi-
demia: Type 1 diabetes is usually characterized by normal
levels of LDL-C and HDL-C and an increased TG level,
whereas type 2 diabetes is associated with a reduced HDL-
C level, an elevated TG level and a normal LDL-C level
[45]. Hyperlipidemia leads to atherosclerosis and chronic
cardiovascular disease (CVD). Reduction in serum choles-
terol level reduces the risk of CVD substantially [45, 46].Our
previous study found that Chinese propolis reduced levels
of TC, LDL-C and very low-density lipoprotein-cholesterol
(VLDL-C) in diabetic rats [18]. In this experiment, the
manifestation of dyslipidemia in STZ-induced diabetic rats
was similar to type 1 diabetes, as Chinese propolis also
signiﬁcantly decreased TC level. LDL oxidation plays an
important role in atherosclerosis and propolis inhibits lipid
peroxidation in vitro and in vivo [47–49]. These results
suggested that propolis may reduce the incidence of CVD
by preventing the increase of cholesterol level and LDL
oxidation.
Activities and chemical composition of propolis often
varied with plant source, extraction, collecting time and
collecting bee [50–52]. Baccharis dracunculifolia DC is the
main plant source of Brazilian propolis, and prenylated
p-coumaric acids are the predominant biologically active
substancesin this propolis[52].Chinese propolisisa poplar-
type propolis, and ﬂavonoids, cinnamic acids and their
esters are the main active components in this propolis
[53]. The diﬀerence in antidiabetic eﬀect between Chi-
nese and Brazilian propolis may be due to the chemical
diﬀerences.
In conclusion, this study demonstrated that Chinese and
Brazilian propolis signiﬁcantly prevent the progression of
STZ-induced diabetes in SD rats and alleviate increased
oxidativestressindiabeticrats.Chinesepropoliscanimprove
lipid metabolism in rats. Further studies are necessary to
reveal whether the anti-inﬂammatory properties of propolis
are involved in the antidiabetic eﬀect.
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